Screener
Neurocrine Biosciences NBIX Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Neurocrine Biosciences in its filing.
Tagged under the XBRL concept us-gaap:LessorOperatingLeasePaymentsToBeReceived.
The source filing: Neurocrine Biosciences’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000914475-26-000026
FAQ
- What is Neurocrine Biosciences's other non-current assets?
- Neurocrine Biosciences (NBIX) reported other non-current assets of $20.1M in Q1 2026.
- How has Neurocrine Biosciences's other non-current assets changed year-over-year?
- Neurocrine Biosciences's other non-current assets decreased by 8.6% year-over-year, from $22M to $20.1M.
- What is the long-term trend for Neurocrine Biosciences's other non-current assets?
- Over 5 years (2020 to 2025), Neurocrine Biosciences's other non-current assets has grown at a 56.2% compound annual growth rate (CAGR), from $6.4M to $59.5M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Neurocrine Biosciences's other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude